 |
市場調査レポート
商品コード
1136936
小児用抗生物質市場：感染症別、投与経路別、流通チャネル別、地域別- 規模、シェア、展望、機会分析、2022年～2030年Pediatric Antibiotics Market, By Infection, By Route Of Administration, By Distribution Channel and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
価格
| 小児用抗生物質市場：感染症別、投与経路別、流通チャネル別、地域別- 規模、シェア、展望、機会分析、2022年～2030年 |
|
出版日: 2022年08月29日
発行: Coherent Market Insights
ページ情報: 英文 176 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 目次
概要
抗生物質は、ある種の細菌感染症の治療や予防に使用されます。抗生物質は、細菌を殺したり、細菌の繁殖や拡散を防いだりすることで効果を発揮します。抗生物質は、小児に最も多く処方される薬で、非特異的上気道感染症や尿路感染症などの重度の細菌感染症の患者さんの命を救う可能性を秘めています。経口投与され、錠剤、液体懸濁液、カプセルの形態で提供されます。また、抗生物質は静脈内投与も行われます。抗生物質は、局所投与用の軟膏、クリーム、ローションなどの形態で提供されています。
市場力学
世界の小児用抗生物質市場で事業を展開する主要企業は、製品承認などの成長戦略の採用に注力しており、これが予測期間中の市場成長の原動力になると予想されます。例えば、2020年1月、米国とカナダ以外ではMSDとして知られる世界有数のバイオ製薬会社であるメルクは、米FDA（米国食品医薬品局）が、6カ月以上の小児におけるクロストリジウム（旧クロストリジウム）ディフィシル関連下痢（CDAD）治療薬としてDIFICID（フィダクソマイシン）経口懸濁液の新薬申請（NDA）およびDIFICID錠剤の追加新薬申請（sNDA）を承認したことを発表しています。さらに、小児用抗生物質の需要の増加が、予測期間中の市場成長を促進すると予想されます。例えば、2021年に国連国際児童基金（UNICEF）は、54カ国で1歳未満の小児に3,160万件の抗生物質治療を実施しました。
本調査の主な特徴
- 本レポートでは、世界の小児用抗生物質市場を詳細に分析し、2021年を基準年とした予測期間（2022-2030年）の市場規模（米国Mn）および年平均成長率（CAGR%）を提供しています。
- また、さまざまなセグメントにわたる潜在的な収益機会を解明し、同市場の魅力的な投資提案マトリクスを解説しています。
- また、市場促進要因、抑制要因、機会、新製品の上市または承認、市場動向、地域別の展望、主要企業が採用する競合戦略など、重要な考察を提供しています。
- 世界の小児用抗生物質市場における主要企業を以下のパラメータに基づいてプロファイルしています-企業プロファイル、製品ポートフォリオ、主なハイライト、財務実績、戦略。
- この調査の一部としてカバーされている主要企業は以下の通りです。Johnson & Johnson, Astellas Pharma, Inc, Pfizer Inc., Novartis AG, Bayer AG, Bristol-Myers Squibb Company, Abbott., DAIICHI SANKYO COMPANY, LIMITED, Dr. Reddy's Laboratories Ltd, Teva Pharmaceuticals USA, Inc., Aurobindo Pharma USA, GlaxoSmithKline Plc., Hikma Pharmaceuticals PLC, Cipla Inc., Glenmark Pharmaceuticals, and Torrent Pharmaceuticals Ltd. Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- 世界の小児用抗生物質市場レポートは、投資家、サプライヤー、製品メーカー、販売業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
- 利害関係者は、世界の小児用抗生物質市場の分析に使用される様々な戦略マトリクスを通じて、意思決定を容易にすることができます。
目次
第1章 調査目的と前提条件
- 調査目的
- 前提条件
- 略語の説明
第2章 市場の展望
- レポート内容
- 市場の定義と範囲
- エグゼクティブサマリー
- 市場スナップショット：感染症別
- 市場スナップショット：投与経路別
- 市場スナップショット：販売チャネル別
- 市場スナップショット：地域別
- コヒーレントオポチュニティマップ（COM）
第3章 市場力学、規制、および動向の分析
- 市場力学
- 促進要因
- 抑制要因
- ビジネスチャンス
- インパクト分析
- 規制のシナリオ
- 市場動向
- 主な発展状況
- 疫学
- PEST分析
- 提携と買収
- ポーターズアナリシス
- 治療アルゴリズム
第4章 小児用抗生物質の世界市場-コロナウイルス（COVID-19）パンデミックの影響
- 経済的影響
- 需要と供給への影響
- COVID-19インパクトアセスメント
第5章 小児用抗生物質の世界市場、感染症別、2017-2030年
- 急性副鼻腔炎
- 急性中耳炎
- 非特異的上気道感染症
- 尿路感染症
- その他
第6章 小児用抗生物質の世界市場（投与経路別）：2017年～2030年
- 経口投与
- 局所投与
- 静脈内投与
- その他
第7章 小児用抗生物質の世界市場（流通チャネル別）：2017年～2030年
- 病院内薬局
- 小売薬局
- eコマース
第8章 小児用抗生物質の世界市場：地域別、2017-2030年
- 北米
- 米国
- カナダ
- ラテンアメリカ
- ブラジル
- メキシコ
- アルゼンチン
- その他のラテンアメリカ地域
- 欧州
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- ロシア
- その他欧州
- アジア太平洋地域
- 中国
- インド
- 日本
- オーストラリア
- 韓国
- ASEAN
- その他アジア太平洋地域
- 中東地域
- GCC
- イスラエル
- その他の中東地域
- アフリカ
- 北アフリカ
- 中央アフリカ
- 南アフリカ
第9章 競合情勢
- ヒートマップ分析
- 市場シェア分析
- Johnson & Johnson
- Astellas Pharma, Inc.
- Pfizer Inc.,
- Novartis AG
- Bayer AG
- Bristol-Myers Squibb Company
- Abbott
- DAIICHI SANKYO COMPANY, LIMITED
- Reddy's Laboratories Ltd
- Teva Pharmaceuticals USA, Inc.
- Aurobindo Pharma USA
- GlaxoSmithKline Plc.,
- Hikma Pharmaceuticals PLC
- Cipla Inc.
- Glenmark Pharmaceuticals
- Torrent Pharmaceuticals Ltd.
第10章 セクション
- 調査手法の紹介
- 出版社について
目次
Product Code: CMI5190
Antibiotics are used to treat or prevent some types of bacterial infection. Antibiotics work by killing bacteria or preventing them from reproducing and spreading. Antibiotics are the most commonly prescribed drugs in children and have the potential to save the lives of patients with severe bacterial infections such as Non-Specific Upper Respiratory Tract Infections, Urinary Tract Infections etc. They are taken orally and come in the form of tablets, liquid suspension, and capsules. Antibiotics are also administered through the intravenous route. Antibiotics are available in the form of ointments, creams, lotions, etc. for topical administration.
Market Dynamics
Key players operating in the global pediatric antibiotics market are focusing on adoption of growth strategies such as product approval, which is expected to drive market growth during the forecast period. For instance, in January 2020, Merck a leading global biopharmaceutical company known as MSD outside of the U.S. and Canada, announced that the U.S. Food and Drug Administration (FDA) had approved a New Drug Application (NDA) for DIFICID (fidaxomicin) for oral suspension, and a supplemental New Drug Application (sNDA) for DIFICID tablets for the treatment of Clostridioides (formerly Clostridium) difficile-associated diarrhea (CDAD) in children aged six months and older. Moreover, increasing demand of pediatric antibiotics is expected to propel market growth over the forecast period. For instance, in 2021, United Nations International Children's Emergency Fund (UNICEF) delivered 31.6 million antibiotic treatments to children under one year of age in 54 countries.
Key features of the study:
- This report provides in-depth analysis of the global pediatric antibiotics market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global pediatric antibiotics market based on the following parameters - Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies
- Key companies covered as a part of this study include Johnson & Johnson, Astellas Pharma, Inc, Pfizer Inc., Novartis AG, Bayer AG, Bristol-Myers Squibb Company, Abbott., DAIICHI SANKYO COMPANY, LIMITED, Dr. Reddy's Laboratories Ltd, Teva Pharmaceuticals USA, Inc., Aurobindo Pharma USA, GlaxoSmithKline Plc., Hikma Pharmaceuticals PLC, Cipla Inc., Glenmark Pharmaceuticals, and Torrent Pharmaceuticals Ltd. Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global pediatric antibiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pediatric antibiotics market.
Detailed Segmentation:
- Global Pediatric antibiotics Market, By Infection :
- Acute Sinusitis
- Acute Otitis Media
- Non-Specific Upper Respiratory Tract Infections
- Urinary Tract Infections
- Others
- Global Pediatric antibiotics Market, By Route of Administration :
- Oral
- Topical
- Intravenous
- Others
- Global Pediatric antibiotics Market, By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- E-Commerce
- Global Pediatric antibiotics Market, By Region:
- North America
- By Country
- U.S.
- Canada
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Country
- South Africa
- Central Africa
- North Africa
- North America
- Company Profiles
- Johnson & Johnson.*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Astellas Pharma, Inc,
- Pfizer Inc
- Novartis AG
- Bayer AG
- Bristol-Myers Squibb Company
- Abbott
- DAIICHI SANKYO COMPANY, LIMITED
- Dr. Reddy's Laboratories Ltd
- Teva Pharmaceuticals USA, Inc
- Aurobindo Pharma USA
- GlaxoSmithKline Plc
- Hikma Pharmaceuticals PLC
- Cipla Inc
- Glenmark Pharmaceuticals
- Torrent Pharmaceuticals Ltd., etc.
- Johnson & Johnson.*
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Infection
- Market Snapshot, By Route Of Administration
- Market Snapshot, By Distribution Channels
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Regulatory Scenario
- Market Trends
- Key Developments
- Epidemiology
- PEST Analysis
- Collaboration and Acquisition
- Porters Analysis
- Treatment Algorithm
4. Global Pediatric Antibiotics Market - Impact of Coronavirus (COVID-19) Pandemic
- Economic Impact
- Impact on Demand and Supply
- COVID-19 Impact Assessments
5. Global Pediatric Antibiotics Market, By Infection, 2017-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Acute Sinusitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Acute Otitis Media
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Non-Specific Upper Respiratory Tract Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Urinary Tract Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
6. Global Pediatric Antibiotics Market, By Route Of Administration, 2017-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
7. Global Pediatric Antibiotics Market, By Distribution Channel, 2017-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
- E-Commerce
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
8. Global Pediatric Antibiotics Market, By Region, 2017-2030, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017-2030,(US$ Mn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Astellas Pharma, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer Inc.,
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- DAIICHI SANKYO COMPANY, LIMITED
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Reddy's Laboratories Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Teva Pharmaceuticals USA, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Aurobindo Pharma USA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GlaxoSmithKline Plc.,
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Hikma Pharmaceuticals PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cipla Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Glenmark Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Torrent Pharmaceuticals Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
10. Section
- Research Methodology
- About us
